Key result
LRP1 inhibition cuts aggregated LDL cholesteryl ester selective uptake by ~80% in vascular smooth muscle cells.
OBJECTIVE: Low-density lipoprotein (LDL) receptor-related protein (LRP1) mediates the internalization of aggregated LDL (agLDL)-LDL trapped in the arterial intima bound to proteoglycans-into human vascular smooth muscle cells (VSMC). LRP1-mediated agLDL uptake induces high-intracellular cholesteryl ester (CE) accumulation. The aim of this study was to characterize the mechanism of agLDL internalization in human VSMC. METHODS AND RESULTS: The lipidic component of LDL was labeled with [3H] and the apolipoprotein component with [(125)I]. We found that >90% of intracellular CE derived from agLDL uptake was not associated with apoB100 degradation but was selectively taken up from agLDL. The inhibition of LRP1 expression by small interfering RNA treatment led to a decrease of 80+/-0.05% in agLDL-CE selective uptake. AgLDL induced intracellular CE accumulation without a concomitant CE synthesis. Cytosolic and cytoskeletal proteins were not required for CE transport. Electron and confocal microscopy experiments indicate that CE derived from agLDL accumulated in adipophilin-stained lipid droplets that were not removable by high-density lipoprotein. CONCLUSIONS: Taken together, these results demonstrate that LRP1 mediates the selective uptake of CE from agLDL and that CE derived from agLDL is not intracellularly processed but stored in lipid droplets in human VSMC.
No takes yet. Share an insight, caveat, or question.
Llorente‐Cortés et al. (2005) studied this question. Small interfering RNA targeting LRP1 expression was evaluated on agLDL-CE selective uptake. Inhibition of LRP1 expression in human vascular smooth muscle cells led to an 80±0.05% decrease in aggregated LDL cholesteryl ester selective uptake.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: